<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018307"><a href="http://purl.obolibrary.org/obo/MONDO_0018307">MONDO:0018307</a></h3>
<p><strong>Label:</strong> neurodegeneration with brain iron accumulation</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011706">MONDO:0011706</a> (Kufor-Rakeb syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0017998">MONDO:0017998</a> (PLA2G6-associated neurodegeneration), <a href="http://purl.obolibrary.org/obo/MONDO_0009739">MONDO:0009739</a> (neurodegeneration with brain iron accumulation 2a), <a href="http://purl.obolibrary.org/obo/MONDO_0009319">MONDO:0009319</a> (pantothenate kinase-associated neurodegeneration),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_256600">OMIM:256600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_606693">OMIM:606693</a>, <a href="http://www.orpha.net/ORDO/Orphanet_157850">Orphanet:157850</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610217">OMIM:610217</a>, <a href="http://www.orpha.net/ORDO/Orphanet_35069">Orphanet:35069</a>, <a href="http://purl.obolibrary.org/obo/OMIM_234200">OMIM:234200</a>, <a href="http://www.orpha.net/ORDO/Orphanet_306674">Orphanet:306674</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314632">Orphanet:314632</a>, <a href="http://www.orpha.net/ORDO/Orphanet_329303">Orphanet:329303</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) and <a href="http://purl.obolibrary.org/obo/HP_0100022">HP:0100022</a> (Abnormality of movement) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) and <a href="http://purl.obolibrary.org/obo/HP_0012823">HP:0012823</a> (Clinical modifier) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) and <a href="http://purl.obolibrary.org/obo/HP_0012823">HP:0012823</a> (Clinical modifier) and <a href="http://purl.obolibrary.org/obo/HP_0100022">HP:0100022</a> (Abnormality of movement) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) and <a href="http://purl.obolibrary.org/obo/HP_0100022">HP:0100022</a> (Abnormality of movement) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0007256">HP:0007256</a> (Abnormal pyramidal signs) and <a href="http://purl.obolibrary.org/obo/HP_0012823">HP:0012823</a> (Clinical modifier) 55.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0012823">HP:0012823</a> (Clinical modifier) 47.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0100022">HP:0100022</a> (Abnormality of movement) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0002493">HP:0002493</a> (Upper motor neuron dysfunction) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 42.78%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002180">HP:0002180</a> (Neurodegeneration) 40.69%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) 36.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) 36.06%</li>
</ul>
</body>
</html>
